Deletion of nuclear factor-κB p50 upregulates fatty acid utilization and contributes to an anti-obesity and high-endurance phenotype in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 309, Issue 6, 2015, Pages E523-E533

  Minegishi, Yoshihiko ^a   Haramizu, Satoshi ^a   Misawa, Koichi ^a   Shimotoyodome, Akira ^a   Hase, Tadashi ^a   Murase, Takatoshi ^a  

^a KAO CORPORATION   (Japan)

Author keywords

Energy metabolism; Fatty acid oxidation; Nuclear factor B

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CARBONYL DERIVATIVE; CHOLESTEROL; FATTY ACID; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETONE BODY; LACTIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN P50; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; NFKB1 PROTEIN, MOUSE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDURANCE; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID OXIDATION; GASTROCNEMIUS MUSCLE; GLYCOGEN MUSCLE LEVEL; LACTATE BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LUNG GAS EXCHANGE; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; LIVER; METABOLISM; OXIDATION REDUCTION REACTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; FATTY ACIDS; INFLAMMATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; NF-KAPPA B P50 SUBUNIT; OBESITY; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHENOTYPE; PHYSICAL ENDURANCE; UP-REGULATION;

EID: 84941653528     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00071.2015     Document Type: Article

References (43)

1. Bass A, Brdiczka D, Eyer P, Hofer S, Pette D. Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem 10: 198–206, 1969.
2. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167–170, 1995.
3. Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291: E99–E107, 2006.
4. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11: 183–190, 2005.
5. Campbell IK, Gerondakis S, O’Donnell K, Wicks IP. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest 105: 1799–1806, 2000.
6. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277–359, 2004.
7. Carter SL, Rennie CD, Hamilton SJ, Tarnopolsky. Changes in skeletal muscle in males and females following endurance training. Can J Physiol Pharmacol 79: 386–392, 2001.
8. Davies KJ, Packer L, Brooks GA. Biochemical adaptation of mitochondria, muscle, and whole-animal respiration to endurance training. Arch Biochem Biophys 209: 539–554, 1981.
9. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274: 32048–32054, 1999.
10. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752–1761, 2004.
11. Gao Z, Yin J, Zhang J, He Q, McGuinness OP, Ye J. Inactivation of NF-kappaB p50 leads to insulin sensitization in liver through posttranslational inhibition of p70S6K. J Biol Chem 284: 18368–18376, 2009.
12. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89: 2595–2600, 2004.
13. Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci USA 105: 7815–7820, 2008.
14. Haramizu S, Nagasawa A, Ota N, Hase T, Tokimitsu I, Murase T. Different contribution of muscle and liver lipid metabolism to endurance capacity and obesity susceptibility of mice. J Appl Physiol 106: 871–879, 2009.
15. Hawley JA, Brouns F, Jeukendrup A. Strategies to enhance fat utilization during exercise. Sports Med 25: 241–257, 1998.
16. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 18: 2195–2224, 2004.
17. Holloszy JO, Kohrt WM, Hansen PA. The regulation of carbohydrate and fat metabolism during and after exercise. Front Biosci 3: D1011–D1027, 1998.
18. Hoover-Plow JL, Gong Y, Shchurin A, Busuttil SJ, Schneeman TA, Hart E. Strain and model dependent differences in inflammatory cell recruitment in mice. Inflamm Res 57: 457–463, 2008.
19. Hotamisligil GS. Mechanisms of TNF-α-induced insulin resistance. Exp Clin Endocrinol Diabetes 107: 119–125, 1999.
20. Hunter RB, Kandarian SC. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 114: 1504–1511, 2004.
21. Ivy JL. Role of carbohydrate in physical activity. Clin Sports Med 18: 469–484, 1999.
22. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116: 571–580, 2006.
23. Lu ZY, Yu SP, Wei JF, Wei L. Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice. Neuroscience 139: 965–978, 2006.
24. Lusk G. The Elements of the Science of Nutrition. Philadelphia, PA, and London: W. B. Saunders, 1928.
25. Murase T, Haramizu S, Shimotoyodome A, Nagasawa A, Tokimitsu I. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice. Am J Physiol Regul Integr Comp Physiol 288: R708–R715, 2005.
26. Murase T, Haramizu S, Shimotoyodome A, Tokimitsu I, Hase T. Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise. Am J Physiol Regul Integr Comp Physiol 290: R1550–R1556, 2006.
27. Péronnet F, Massicotte D. Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16: 23–29, 1991.
28. Planavila A, Laguna JC, Vazquez-Carrera M. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 280: 17464–17471, 2005.
29. Powers SK, Lawler J, Criswell D, Lieu FK, Martin D. Aging and respiratory muscle metabolic plasticity: effects of endurance training. J Appl Physiol 72: 1068–1073, 1992.
30. Rakhshandehroo M, Knoch B, Müller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res 2010: 612089, 2010.
31. Razeghi P, Wang ME, Youker KA, Golfman L, Stepkowski S, Taegtmeyer H. Lack of NF-kappaB1 (p105/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart. Cardiovasc Res 74: 133–139, 2007.
32. Rector RS, Thyfault JP, Morris RT, Laye MJ, Borengasser SJ, Booth FW, Ibdah JA. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 294: G619–G626, 2008.
33. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118: 2992–3002, 2008.
34. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80: 321–330, 1995.
35. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 87: 377–389, 1996.
36. Srere PA. Citrate synthase. Methods Enzymol 13: 3–11, 1969.
37. Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, Mandarino LJ, Musi N. Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 55: 760–767, 2006.
38. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393: 790–793, 1998.
39. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100: 15924–15929, 2003.
40. Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, Jung DY, Ko HJ, Ong H, Kim JK, Mynatt R, Martin RJ, Keenan M, Gao Z, Ye J. Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem 285: 4637–4644, 2010.
41. Vijayakumar RS, Lin Y, Shia KS, Yeh YN, Hsieh WP, Hsiao WC, Chang CP, Chao YS, Hung MS. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors. Int J Obes (Lond) 36: 999–1006, 2012.
42. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2: e294, 2004.
43. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796–1808, 2003.